These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fusion inhibition--a major but costly step forward in the treatment of HIV-1. Tashima KT; Carpenter CC N Engl J Med; 2003 May; 348(22):2249-50. PubMed ID: 12773653 [No Abstract] [Full Text] [Related]
5. HIV infection--a new drug and new costs. Steinbrook R N Engl J Med; 2003 May; 348(22):2171-2. PubMed ID: 12773643 [No Abstract] [Full Text] [Related]
7. Enfuvirtide (Fuzeon): the first fusion inhibitor. Williams IG Int J Clin Pract; 2003 Dec; 57(10):890-7. PubMed ID: 14712892 [TBL] [Abstract][Full Text] [Related]
8. US FDA approves new class of HIV therapeutics. Robertson D Nat Biotechnol; 2003 May; 21(5):470-1. PubMed ID: 12721558 [No Abstract] [Full Text] [Related]
13. Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States. Hornberger J; Kilby JM; Wintfeld N; Green J AIDS Res Hum Retroviruses; 2006 Mar; 22(3):240-7. PubMed ID: 16545010 [TBL] [Abstract][Full Text] [Related]
14. Enfuvirtide, a new drug for HIV infection. Fletcher CV Lancet; 2003 May; 361(9369):1577-8. PubMed ID: 12747873 [No Abstract] [Full Text] [Related]
15. Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy. Hornberger J; Green J; Wintfeld N; Cavassini M; Rockstroh J; Giuliani G; De Carli C; Lazzarin A HIV Clin Trials; 2005; 6(2):92-102. PubMed ID: 15983893 [TBL] [Abstract][Full Text] [Related]
16. Drug profile: enfuvirtide (Fuzeon, ENF, T-20). Pham PA Hopkins HIV Rep; 2003 May; 15(3):1-2. PubMed ID: 12809104 [No Abstract] [Full Text] [Related]
17. [Enfuvirtide, mechanism of action and pharmacological properties]. Kapić E; Becić F; Zvizdić S Med Arh; 2005; 59(5):313-6. PubMed ID: 16134757 [TBL] [Abstract][Full Text] [Related]
18. Enfuvirtide antiviral activity despite rebound viremia and resistance mutations: fitness tampering or a case of persistent braking on entering? Morse C; Maldarelli F J Infect Dis; 2007 Feb; 195(3):318-21. PubMed ID: 17205468 [No Abstract] [Full Text] [Related]
19. The lifetime cost of current human immunodeficiency virus care in the United States. Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130 [TBL] [Abstract][Full Text] [Related]
20. Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough. Meyohas MC; Lacombe K; Carbonne B; Morand-Joubert L; Girard PM AIDS; 2004 Sep; 18(14):1966-8. PubMed ID: 15353987 [No Abstract] [Full Text] [Related] [Next] [New Search]